Method for treating primary glomerulonephritis

TW202637128APending Publication Date: 2026-09-16禮邦醫藥(江蘇)股份有限公司
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114149093
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-16
Filing Date
2025-12-15
Publication Date
2026-09-16

Smart Images

  • Figure TWG2TA001076751_001
    Figure TWG2TA001076751_001
  • Figure TWG2TA001076751_002
    Figure TWG2TA001076751_002
  • Figure TWG2TA001076751_003
    Figure TWG2TA001076751_003
Patent Text Reader

Abstract

This disclosure relates to a method for treating primary glomerulonephritis, such as focal segmental glomerulosclerosis (FSGS), IgA nephropathy (IgAN), or glomerular intercyclic membrane proliferative glomerulonephritis (MsPGN). The present disclosure relates to methods for treating primary glomerulonephritis, eg, focal segmental glomerulosclerosis (FSGS), IgA nephropathy (IgAN) or mesangial proliferative glomerulonephritis (MsPGN).
Need to check novelty before this filing date? Find Prior Art